-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA feedback supports SOF-SKN Phase II plans

ASX·10/07/2026 21:15:37

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.